Literature DB >> 19233005

Efficacy of intralesional 5-fluorouracil and triamcinolone in the treatment of keloids.

Steven P Davison1, Joseph H Dayan, Mark W Clemens, Smitha Sonni, Antai Wang, Amy Crane.   

Abstract

BACKGROUND: Keloids are a common problem with significant recurrence rates despite intralesional steroid treatment and multimodal therapy.
OBJECTIVE: The purpose of this study was to evaluate the efficacy of using a 5-fluorouracil (5-FU)/steroid mixture to treat keloids over the past 7 years, comparing the results with use of steroid treatment alone.
METHODS: Patient charts from 1999 to 2006 were reviewed. Patients were stratified into 3 groups: (1) 5-FU/steroid without excision; (2) 5-FU/steroid with excision; and (3) steroid treatment with excision. The percentage of lesion size reduction and symptoms were evaluated.
RESULTS: A total of 102 keloids were identified in a retrospective review. Patients who underwent the 5-FU/steroid combination with excision had a 92% average reduction in lesion size compared with 73% in the group of patients who did not receive 5-FU. Patients who received 5-FU/steroid without excision had an average lesion size reduction of 81%. Differences in complication rates were not statistically significant.
CONCLUSIONS: Combination 5-FU/triamcinolone is superior to intralesional steroid therapy in the treatment of keloids.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19233005     DOI: 10.1016/j.asj.2008.11.006

Source DB:  PubMed          Journal:  Aesthet Surg J        ISSN: 1090-820X            Impact factor:   4.283


  17 in total

Review 1.  [Therapy of hypertrophic scars and keloids].

Authors:  R Aschoff
Journal:  Hautarzt       Date:  2014-12       Impact factor: 0.751

2.  Comparison of Intralesional Triamcinolone Acetonide, 5-Fluorouracil, and Their Combination for the Treatment of Keloids.

Authors:  Sunil Srivastava; Aditya Nanasaheb Patil; Chaitra Prakash; Hiranmayi Kumari
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-11-01       Impact factor: 4.730

3.  Treatment of Small Keloids Using Intralesional 5-fluorouracil and Triamcinolone Acetonide versus Intralesional Bleomycin and Triamcinolone Acetonide.

Authors:  Saurabh Sharma; Kajal Vinay; Roopam Bassi
Journal:  J Clin Aesthet Dermatol       Date:  2021-03-01

4.  Downregulated cytotoxic CD8+ T-cell identifies with the NKG2A-soluble HLA-E axis as a predictive biomarker and potential therapeutic target in keloids.

Authors:  Heng Xu; Zhu Zhu; Jian Hu; Jiawei Sun; Yan Wo; Xianshu Wang; Hongzhi Zou; Bin Li; Yixin Zhang
Journal:  Cell Mol Immunol       Date:  2022-01-17       Impact factor: 22.096

5.  Eradication of keloids: Surgical excision followed by a single injection of intralesional 5-fluorouracil and botulinum toxin.

Authors:  Adel Michel Wilson
Journal:  Can J Plast Surg       Date:  2013

6.  Triamcinolone acetonide combined with 5-fluorouracil suppresses urethral scar fibroblasts autophagy and fibrosis by increasing miR-192-5p expression.

Authors:  Weidong Zhou; Qingsong Yu; Junjie Ma; Chengdang Xu; Denglong Wu; Chao Li
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

7.  The management of helical rim keloids with excision, split thickness skin graft and intralesional triamcinolone acetonide.

Authors:  Ibrahim Abdul Rasheed; Asuku E Malachy
Journal:  J Cutan Aesthet Surg       Date:  2014-01

Review 8.  Recent developments in the use of intralesional injections keloid treatment.

Authors:  Aurelia Trisliana Perdanasari; Davide Lazzeri; Weijie Su; Wenjing Xi; Zhang Zheng; Li Ke; Peiru Min; Shaoqing Feng; Yi Xin Zhang; Paolo Persichetti
Journal:  Arch Plast Surg       Date:  2014-11-03

Review 9.  5-Fluorouracil in the Treatment of Keloids and Hypertrophic Scars: A Comprehensive Review of the Literature.

Authors:  Vidhi V Shah; Adam S Aldahan; Stephanie Mlacker; Mohammed Alsaidan; Sahal Samarkandy; Keyvan Nouri
Journal:  Dermatol Ther (Heidelb)       Date:  2016-04-22

10.  Management of keloids and hypertrophic scars: current and emerging options.

Authors:  Gerd G Gauglitz
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.